Abstract: Pellagra is a nutritional disease caused by a deficiency of niacin. It may lead to death if not identified and treated timely. We review the literature and report a female patient presented with clinical features of pellagra as a complication of Crohn's disease. Keywords: Crohn's disease; Niacin; Niacinamide; Pellagra Pellagra was first described in 1735 by the Spanish physician Gaspar Casal. Chronic alcoholism can be a main cause of pellagra in some developed countries.
In developing countries, the disease may be increasing among HIV-positive patients. Other causes include carcinoid syndrome, Hartnup disease, infection, and isoniazid or fluorouracil therapy. We report here a case of pellagra affecting a Crohn's disease (CD) patient, which is rarely reported in China.
A 49-year-old woman with CD was admitted to our hospital with abdominal pain, diarrhea and a temperature of 38°C in 2014.
She had been diagnosed with CD for three years and was treated with mesalazine and prednisone. In 2012, a lower enteroscopy showed fistulas arising from the transverse colon, ileum and descending duodenum. In April 2013, the disease flared for the second time and infliximab was administered for 3 times with unsatisfactory results. After that, the patient followed a very strict diet that was basically limited to pasta, avoiding red meat, fish, milk, and eggs while continuing the treatment with mesalazine.
On admission, the patient had normal weight and normal blood pressure with temperature of 37.6°C. Physical examination only revealed the surgery scars and skin change without itches or pain. Dark-brown coloration and scaly desquamation of the skin were noticed on the neck, dorsum of the hands, and ankles, which would aggravate after sun exposure ( Figure 1 ). The neck and ankles were tender.
Laboratory test results at admission were as follows: he- Pellagra is rarely reported as a complication of CD caused by a deficiency of niacin. 2 The prevalence of the disease might be misleading due to underdiagnosis. 3 Pellagra is divided into two forms: Pellagra itself can perpetuate further malnutrition due to GI effects. [6] [7] Azathioprine treatment has also been reported to induce pellagra. 8 There are currently no tests or laboratory markers of diagnostic value in pellagra. Abnormal 5-OH-indoleacetic acid levels in a 24-hour urine test have been proposed as a potential marker for pellagra. Elevated levels may be due to a carcinoid tumor and reduced levels could indicate tryptophan sequestration for the synthesis of niacin, causing depleted serotonin levels. 9 However, whether it has any value in diagnosing is still controversial. Blood levels of NAD and NADP have not been found to correlate well with tissue levels in patients with pellagra as they are not reduced. 5 The levels of the niacinamide metabolites 1-methylnicotinamide and 1-methyl-2-pyridone-5-carboxymide in relation to blood creatinine levels in an Angolan population with and at risk of pellagra was proved to be useful for identifying vulnerable populations in developing countries. are nonspecific in many cases. 9 Histologically, a perivascular lymphocytic infiltrate in the upper dermis and edema in the papillary dermis can be found in the acute stages. Later on, hyperkeratosis, parakeratosis, and epidermal atrophy are observed.
Pellagra is caused by a deficiency of the coenzymes nicotinamide adenine dinucleotide (NAD) and NAD phosphate (NADP), which participate in numerous processes including glycolysis, the metabolism of amino acids and proteins, and the generation of high-energy phosphate bonds. This would explain why pellagra mainly affects tissues with a high rate of cell turnover, such as the skin and the digestive tract, and tissues with high energy needs, such as the brain. Niacin (or its amide niacinamide) is absorbed directly through the intestinal wall or synthesized from the essential amino acid tryptophan. 9, 10 Most IBD patients have dysfunction in absorption, and strict diet needs might put them to a dilemma.
In conclusion, since pellagra still occurs, we should take this disease into account in cases of CD patients with strict diet needs, especially with the predisposing factor of poor diet and serious diarrhea, and for those treated with immunomodulators. Pellagra can be an easily treated condition if timely recognized. q
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